Bain Capital, a global private investment firm, has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma ...

SelectQuote shares surged ~30% on strong Q2 results and a $350M Bain Capital-led investment. Revenue grew 19%. Click to see ...

Carlyle is wrapping up a two-year fundraising campaign for its eighth secondaries flagship, CEO Harvey Schwartz said on the ...

Kestra Medical Technologies Ltd. has filed for an initial public offering, showing revenue growth that nearly tripled.

SelectQuote (SLQT) announced that the company signed a $350M strategic investment from funds managed by Bain Capital, Morgan Stanley Private ...

The carve-out acquisition will allow Bain to capitalize on the “promising signs for growth” in the Japanese life sciences ...

Chemical companies in the US and Europe began exiting the pharmaceutical industry in the mid-1990s, when the British firm ICI ...

Bain said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare industry.

Private equity firm Bain Capital agreed to acquire Mitsubishi Chemical Group’s pharmaceutical unit, adding to a dealmaking boom in Japan. The deal values Mitsubishi Tanabe Pharma at about ¥510 ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...